ECT: Effective, but standards vary widely

IN a crowded conference room in Hobart, the banter is reaching boiling point. Psychiatrists from across the country have convened to discuss developments in electroconvulsive therapy (ECT) and neuropsychology as part of last week's Royal Australian & New Zealand College of Psychiatrists annual congress. And the topic has turned to the tricky balancing act of maximising efficacy while minimising side effects.
Read More

Will regulating alternative health practitioners improve public safety?

Should alternative medicine practitioners be better regulated? Concerns over the variation between quality, skills experience and ethics has led to a government consultation to discuss the options. Support for more stringent regulation has been broad-- and it's come from the groups representing alternative medicine themselves.
Read More

Surgery successful, but the sex needs help: prostate cancer

LIMP, shrimp, wet and dry. That's how one patient sums up his post-prostate cancer surgery state. Limp because he could no longer get an erection, shrimp because his penis had shrunk a couple of centimetres, wet because he was incontinent and dry because he couldn't ejaculate any more. Every year in Australia about 20,000 men are diagnosed with prostate cancer, the second most common cancer after skin cancer. Survival rates are high, about 95 per cent in cases where it's caught early and is still localised. But while treatment is often effective, it nearly always leaves scars, even in best-case scenarios.
Read More

Banking on a breakthrough: cord blood

A growing number of parents are choosing to have their children's cord blood stored in private banks at a cost of anywhere from $3300 if you pay a lump sum to $5460 if you spread it over 18 years. The hope is that the stem cells contained in the cord blood could provide invaluable treatment one day. But some experts worry that marketing by private cord blood banks may pressure vulnerable parents, fearing "what if's", to gamble their baby bonus or savings on treatments that aren't yet based on sound evidence.
Read More